information material which might affect to negative change in the price of DCON's share which were the fact that (1) the net profit in financial statements of 2016 significantly decreases because of

affect to negative change in the price of DCON's share which was the fact that (1) the net profit in financial statements of 2016 significantly decreases because of decreased revenue and increased

summary of the Company’s operating performance in the second quarter of 2017 and 2016 is shown in the following table: 2Q17 1Q17 %Change 2Q16 %Change [Amount: in Baht Million] Q-o-Q Y-o-Y [2Q17 VS. 1Q17

, representing a decline of 22.1% Y-o-Y and decrease of 8.9% Q-o-Q. The Y-o-Y decrease was primarily attributed to the reduction in gross profit rate, the substantial effect of a change in foreign currency

Revenue by Product Line for the three months period ended March 31 (YoY) Product Line/ Business Group Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 31 March 2018

(“the Group”) as follow: Q3-2019 Q2-2020 Q3-2020 9M-2019 9M-2020 Change THB Mn THB Mn THB Mn %QoQ %YoY THB Mn THB Mn %YoY Sales of goods and services 1,142.7 1,139.5 1,182.8 3.8% 3.5% 3,399.0 3,438.0 1.1

disturbed by sharp decline in Chinese tourists, turned off by series of unfortunate events. The Chinese tourists are one of a key customer of the company. Consequently, domestic sales experienced a 1 6.69

2018, Sales revenue of the Company was recorded at THB 1,256.44 million and THB 983.36 million respectively or equivalent to a drop of 21.73% which is considered a consecutive decline from the last

Baht 24.46 million, a decrease of 62.93% compared to 2017. Final earnings per share resulted at Baht 1.15. Total Revenues 2018 2017 Change (Million Baht) (Million Baht) (%) Sales 2,020.63 2,147.64 (5.91

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change